Atlas Trials

BMN 110 US Expanded Access Program

Clinical trial NCT01858103 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT01858103
Sponsor
BioMarin Pharmaceutical
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Mucopolysaccharidosis IVAMorquio A SyndromeMPS IVA

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.